Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01062009 · ClinicalTrials.gov registry record · Phase 1
Safety and Dose Escalation Study of Zinc Supplementation in Critically Ill Children
A Phase 1 study, sponsored by UCSF Benioff Children's Hospital Oakland.
- Completed
- Registry status
- Phase 1
- Development phase
- 24
- Enrollment target
NCT01062009: Completed Phase 1 study, sponsored by UCSF Benioff Children's Hospital Oakland.
NCT01062009 is a Phase 1 study that has completed, run by UCSF Benioff Children's Hospital Oakland. The registered enrollment target is 24 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01062009, a Phase 1 study, has completed, sponsored by UCSF Benioff Children's Hospital Oakland.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 24 participants
- Enrollment target
Study Summary
The purpose of the study is 1) to determine whether administration of intravenous zinc to critically ill children is safe, and 2) to determine an appropriate dose of zinc supplementation.
Interventions
- DRUG Zinc sulfate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2008-11 |
| Est. Completion | 2014-11 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01062009
The ClinicalTrials.gov registry entry for NCT01062009 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is UCSF Benioff Children's Hospital Oakland, which has 52 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Zinc sulfate is the first listed.
NCT01062009 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01062009 about?
NCT01062009 is a clinical study titled "Safety and Dose Escalation Study of Zinc Supplementation in Critically Ill Children". The purpose of the study is 1) to determine whether administration of intravenous zinc to critically ill children is safe, and 2) to determine an appropriate dose of zinc supplementation.
What is the current status of trial NCT01062009?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 24 participants. The study started on 2008-11. Estimated completion is 2014-11.
What interventions are being tested in trial NCT01062009?
The interventions under investigation include: Zinc sulfate (DRUG).
Who is sponsoring clinical trial NCT01062009?
This trial is sponsored by UCSF Benioff Children's Hospital Oakland, which has 52 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.